The Ratio of CD86+/CD163+ Macrophages Predicts Postoperative Recurrence in Stage II-III Colorectal Cancer

Tumor-associated macrophages (TAMs) are pivotal for tumor progression and metastasis. We investigated the stromal CD86+TAM/CD163+TAM (CD86/CD163) ratio as a novel prognostic biomarker for stage II-III colorectal cancer (CRC). Two independently clinical cohorts of stage II-III CRC were retrospectivel...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Guozeng, Jiang, Lei, Ye, Cheng, Qin, Guizhen, Luo, Zhanxiong, Mo, Yuzhen, Chen, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427131/
https://www.ncbi.nlm.nih.gov/pubmed/34512652
http://dx.doi.org/10.3389/fimmu.2021.724429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427131/
https://www.ncbi.nlm.nih.gov/pubmed/34512652
http://dx.doi.org/10.3389/fimmu.2021.724429

Ejemplares similares